Cargando…
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Hypoxia is frequently observed in solid tumors and also one of the major obstacles for effective cancer therapies. Cancer cells take advantage of their ability to adapt hypoxia to initiate a special transcriptional program that renders them more aggressive biological behaviors. Hypoxia-inducible fac...
Autores principales: | Yu, Tianchi, Tang, Bo, Sun, Xueying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368132/ https://www.ncbi.nlm.nih.gov/pubmed/28332352 http://dx.doi.org/10.3349/ymj.2017.58.3.489 |
Ejemplares similares
-
Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
por: Luo, Shuang, et al.
Publicado: (2022) -
Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
por: Xiong, Anji, et al.
Publicado: (2017) -
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
por: Bessho, Ryoichi, et al.
Publicado: (2019) -
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021) -
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
por: Seeber, Laura M. S., et al.
Publicado: (2010)